Cargando…

Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials

BACKGROUND: The use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a better understanding of the impact of treatments on the ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbieri, Antoine, Peyhardi, Jean, Conroy, Thierry, Gourgou, Sophie, Lavergne, Christian, Mollevi, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615461/
https://www.ncbi.nlm.nih.gov/pubmed/28950850
http://dx.doi.org/10.1186/s12874-017-0410-9
_version_ 1783266590541742080
author Barbieri, Antoine
Peyhardi, Jean
Conroy, Thierry
Gourgou, Sophie
Lavergne, Christian
Mollevi, Caroline
author_facet Barbieri, Antoine
Peyhardi, Jean
Conroy, Thierry
Gourgou, Sophie
Lavergne, Christian
Mollevi, Caroline
author_sort Barbieri, Antoine
collection PubMed
description BACKGROUND: The use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a better understanding of the impact of treatments on the everyday life and care of patients. Amongst the models that are used for the longitudinal analysis of HRQoL, we focused on the mixed models from item response theory, to directly analyze raw data from questionnaires. METHODS: We reviewed the different item response models for ordinal responses, using a recent classification of generalized linear models for categorical data. Based on methodological and practical arguments, we then proposed a conceptual selection of these models for the longitudinal analysis of HRQoL in cancer clinical trials. RESULTS: To complete comparison studies already present in the literature, we performed a simulation study based on random part of the mixed models, so to compare the linear mixed model classically used to the selected item response models. As expected, the sensitivity of the item response models to detect random effects with lower variance is better than that of the linear mixed model. We then used a cumulative item response model to perform a longitudinal analysis of HRQoL data from a cancer clinical trial. CONCLUSIONS: Adjacent and cumulative item response models seem particularly suitable for HRQoL analysis. In the specific context of cancer clinical trials and the comparison between two groups of HRQoL data over time, the cumulative model seems to be the most suitable, given that it is able to generate a more complete set of results and gives an intuitive illustration of the data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-017-0410-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5615461
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56154612017-09-28 Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials Barbieri, Antoine Peyhardi, Jean Conroy, Thierry Gourgou, Sophie Lavergne, Christian Mollevi, Caroline BMC Med Res Methodol Research Article BACKGROUND: The use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a better understanding of the impact of treatments on the everyday life and care of patients. Amongst the models that are used for the longitudinal analysis of HRQoL, we focused on the mixed models from item response theory, to directly analyze raw data from questionnaires. METHODS: We reviewed the different item response models for ordinal responses, using a recent classification of generalized linear models for categorical data. Based on methodological and practical arguments, we then proposed a conceptual selection of these models for the longitudinal analysis of HRQoL in cancer clinical trials. RESULTS: To complete comparison studies already present in the literature, we performed a simulation study based on random part of the mixed models, so to compare the linear mixed model classically used to the selected item response models. As expected, the sensitivity of the item response models to detect random effects with lower variance is better than that of the linear mixed model. We then used a cumulative item response model to perform a longitudinal analysis of HRQoL data from a cancer clinical trial. CONCLUSIONS: Adjacent and cumulative item response models seem particularly suitable for HRQoL analysis. In the specific context of cancer clinical trials and the comparison between two groups of HRQoL data over time, the cumulative model seems to be the most suitable, given that it is able to generate a more complete set of results and gives an intuitive illustration of the data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-017-0410-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-09-26 /pmc/articles/PMC5615461/ /pubmed/28950850 http://dx.doi.org/10.1186/s12874-017-0410-9 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Barbieri, Antoine
Peyhardi, Jean
Conroy, Thierry
Gourgou, Sophie
Lavergne, Christian
Mollevi, Caroline
Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
title Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
title_full Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
title_fullStr Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
title_full_unstemmed Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
title_short Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
title_sort item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615461/
https://www.ncbi.nlm.nih.gov/pubmed/28950850
http://dx.doi.org/10.1186/s12874-017-0410-9
work_keys_str_mv AT barbieriantoine itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials
AT peyhardijean itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials
AT conroythierry itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials
AT gourgousophie itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials
AT lavergnechristian itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials
AT mollevicaroline itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials